{
  "label": "clinical_signal_03_dx_renal_biomarker_study_016",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:4be081c7bb859b36a339c979a70861ab7561cd7a0a50ba2411cb9e6f06ed9cf1",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:57:07.467372",
  "content": "## 2024-06-17 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 85\n- Active: 79\n- Screen Failures Cumulative: 30\n- Withdrawals Cumulative: 6\n\n#### By Cohort\n- 10mg: 19\n- 25mg: 21\n- 50mg: 22\n- 100mg: 23\n\n### Biomarkers By Cohort\n#### 10mg\n- KIM-1 (ng/mL) Mean: 2.4\n- KIM-1 (ng/mL) SD: 0.43\n- NGAL (ng/mL) Mean: 44.2\n- NGAL (ng/mL) SD: 18.1\n- Cystatin C (mg/L) Mean: 0.92\n- Cystatin C (mg/L) SD: 0.14\n- eGFR (mL/min) Mean: 64.0\n- eGFR (mL/min) SD: 8.1\n- UACR (mg/g) Mean: 42.8\n- UACR (mg/g) SD: 27.9\n- Serum Creatinine (mg/dL) Mean: 1.1\n- Serum Creatinine (mg/dL) SD: 0.21\n- Urine Protein (mg/dL) Mean: 19.3\n- Urine Protein (mg/dL) SD: 8.2\n- Urine Output (mL/24h) Mean: 1667\n- Urine Output (mL/24h) SD: 400\n\n#### 25mg\n- KIM-1 (ng/mL) Mean: 1.05\n- KIM-1 (ng/mL) SD: 0.47\n- NGAL (ng/mL) Mean: 50.1\n- NGAL (ng/mL) SD: 11.9\n- Cystatin C (mg/L) Mean: 1.1\n- Cystatin C (mg/L) SD: 0.09\n- eGFR (mL/min) Mean: 66.0\n- eGFR (mL/min) SD: 12.8\n- UACR (mg/g) Mean: 45.6\n- UACR (mg/g) SD: 12.8\n- Serum Creatinine (mg/dL) Mean: 1.26\n- Serum Creatinine (mg/dL) SD: 0.26\n- Urine Protein (mg/dL) Mean: 18.6\n- Urine Protein (mg/dL) SD: 8.1\n- Urine Output (mL/24h) Mean: 2015\n- Urine Output (mL/24h) SD: 342\n\n#### 50mg\n- KIM-1 (ng/mL) Mean: 2.35\n- KIM-1 (ng/mL) SD: 0.58\n- NGAL (ng/mL) Mean: 62.2\n- NGAL (ng/mL) SD: 13.7\n- Cystatin C (mg/L) Mean: 1.2\n- Cystatin C (mg/L) SD: 0.12\n- eGFR (mL/min) Mean: 64.4\n- eGFR (mL/min) SD: 9.5\n- UACR (mg/g) Mean: 47.4\n- UACR (mg/g) SD: 31.5\n- Serum Creatinine (mg/dL) Mean: 1.0\n- Serum Creatinine (mg/dL) SD: 0.25\n- Urine Protein (mg/dL) Mean: 23.1\n- Urine Protein (mg/dL) SD: 4.9\n- Urine Output (mL/24h) Mean: 1627\n- Urine Output (mL/24h) SD: 392\n\n#### 100mg\n- KIM-1 (ng/mL) Mean: 2.77\n- KIM-1 (ng/mL) SD: 0.55\n- NGAL (ng/mL) Mean: 79.4\n- NGAL (ng/mL) SD: 19.8\n- Cystatin C (mg/L) Mean: 1.04\n- Cystatin C (mg/L) SD: 0.11\n- eGFR (mL/min) Mean: 69.1\n- eGFR (mL/min) SD: 9.2\n- UACR (mg/g) Mean: 73.4\n- UACR (mg/g) SD: 31.7\n- Serum Creatinine (mg/dL) Mean: 1.14\n- Serum Creatinine (mg/dL) SD: 0.24\n- Urine Protein (mg/dL) Mean: 19.6\n- Urine Protein (mg/dL) SD: 3.7\n- Urine Output (mL/24h) Mean: 1869\n- Urine Output (mL/24h) SD: 338\n\n### Dose Response\n- KIM-1 Dose Correlation (r): 0.361\n- NGAL Dose Correlation (r): 0.404\n- eGFR Dose Correlation (r): -0.49\n- UACR Dose Correlation (r): 0.408\n\n### Safety Labs\n- Hemoglobin (g/dL) Mean: 12.5\n- Hemoglobin (g/dL) SD: 1.5\n- Hematocrit (%) Mean: 38.1\n- Hematocrit (%) SD: 3.4\n- WBC (k/\u00b5L) Mean: 7.6\n- WBC (k/\u00b5L) SD: 1.8\n- Platelets (k/\u00b5L) Mean: 218\n- Platelets (k/\u00b5L) SD: 47\n- Sodium (meq/L) Mean: 141.6\n- Sodium (meq/L) SD: 2.7\n- Potassium (meq/L) Mean: 4.3\n- Potassium (meq/L) SD: 0.4\n- Bicarbonate (meq/L) Mean: 27.4\n- Bicarbonate (meq/L) SD: 2.5\n- Phosphorus (mg/dL) Mean: 3.8\n- Phosphorus (mg/dL) SD: 0.4\n\n### Adverse Events\n- AE ID: RB-AE-1666\n  - Description: headache\n  - Grade: 1\n  - Relatedness: unlikely related\n  - Resolved: false\n  - Cohort: 50mg\n- AE ID: RB-AE-1674\n  - Description: dizziness\n  - Grade: 1\n  - Relatedness: not related\n  - Resolved: true\n  - Cohort: 100mg\n\n### Protocol Deviations\n- No protocol deviations reported.\n\n### Events\n- Renal ultrasound images uploaded to central imaging core\n- eCRF query resolution: 10 queries closed this week\n\n### Notes\n- Week 16: Renal biomarker collection on schedule. 85 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 16,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}